Related Experiment Video
Updated: Sep 8, 2026

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
Published on: August 19, 2020
Haemodynamic changes with paracetamol in critically-ill children
Samiran Ray1, Thomas Brick2, Sainath Raman1
1Paediatric Intensive Care Unit, Great Ormond Street Hospital, London, WC1N 3JH, UK; Respiratory, Anaesthesia and Critical Care Section, UCL Institute of Child Health, London, WC1N 1EH, UK.
Insights
Paracetamol administration in critically-ill children causes a modest reduction in blood pressure. This effect is more pronounced in children with fever but not significantly related to body surface area to weight ratio.
Area of Science:
- Pediatric critical care medicine
- Pharmacology
- Cardiovascular physiology
Background:
- Paracetamol (acetaminophen) is commonly used for fever and pain management in children.
- Previous studies suggest paracetamol may reduce blood pressure in febrile, critically-ill adults.
- The impact of paracetamol on blood pressure in critically-ill children requires further investigation.
Purpose of the Study:
- To investigate the effect of paracetamol on blood pressure in critically-ill children.
- To determine if fever or body surface area to weight ratio influences this effect.
- To explore the hemodynamic mechanisms underlying blood pressure changes.
Main Methods:
- Prospective observational study over 12 months.
- Inclusion of children aged 0-16 years admitted to pediatric intensive care.
- Utilized pulse contour analysis for continuous blood pressure monitoring during paracetamol administration.
Main Results:
- Mean arterial blood pressure decreased by 4.7% post-paracetamol administration.
- The blood pressure nadir occurred 2 hours after dosing.
- A trend towards a greater reduction was observed in febrile children (6.4%), though not statistically significant.
- No clear relationship was found with body surface area to weight ratio.
- Changes in heart rate or stroke volume poorly correlated with blood pressure changes, suggesting a role for systemic vascular resistance.
Conclusions:
- Paracetamol administration leads to a significant, albeit modest, reduction in blood pressure in critically-ill children.
- The observed hypotension is likely mediated by a decrease in systemic vascular resistance.
- Further research is warranted to fully elucidate the hemodynamic effects and clinical implications.
Purpose:
Paracetamol has been associated with a reduction in blood pressure, especially in febrile, critically-ill adults. We hypothesised that blood pressure would fall following administration of paracetamol in critically-ill children and this effect would be greater during fever and among children with a high body surface area to weight ratio.
Methods:
A 12-month prospective observational study of children (0-16years) admitted to paediatric intensive care, who underwent pulse contour analysis and received paracetamol concurrently.
Results:
Mean arterial blood pressure decreased significantly by 4.7% from baseline (95% CI 1.75-8.07%) in 31 children following 148 doses of paracetamol. The nadir was 2-hour post-dose. The effect was pronounced in children with fever at baseline (6.4%, 95% CI 2.8-10%), although this was not statistically significant. There was no simple relationship between this effect and body surface area to weight ratio. The association between a change in blood pressure and changes in heart rate or measured stroke volume was poor; therefore it was likely that a change in the systemic vascular resistance contributes most to this effect.
Conclusion:
There is a significant but modest reduction in blood pressure post-paracetamol in critically-ill children. This is likely related to a change in systemic vascular resistance.
Related Concept Videos
Factors Affecting Drug Response: Overview
Drug Dosing: Infants and Children
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

